natgillin/translations-raw huggingface dataset:
Round, biconvex, yellow tablets marked with ‘90’ above ‘T’ on one side and plain on the other.
Okrugle, bikonveksne, žute tablete, s jedne strane označene oznakom '90' iznad slova 'T', s druge strane bez oznake.
Round, brown, film-coated tablets with “16” debossed on one side.
Okrugle, smeđe, filmom obložene tablete s utisnutim “16” na jednoj strani.
Round, dark-violet, film-coated tablets with “12” debossed on one side.
Okrugle, tamno ljubičaste, filmom obložene tablete s utisnutim “12” na jednoj strani.
Round, dark-yellow, film-coated tablets with “14” debossed on one side.
Okrugle, tamno žute, filmom obložene tablete s utisnutim “14” na jednoj strani.
Round, green, film-coated tablets with “8” debossed on one side.
Okrugle, zelene, filmom obložene tablete s utisnutim “8” na jednoj strani.
Round, light beige film-coated tablet with “112”on one side.
Okrugla, svjetlobež, filmom obložena tableta s oznakom "112" na jednoj strani.
Round, light-yellow, film-coated tablets with “2” debossed on one side.
Okrugle, svijetlo žute, filmom obložene tablete s utisnutim “2” na jednoj strani.
Round, orange, film-coated tablets with “10” debossed on one side.
Okrugle, narančaste, filmom obložene tablete s utisnutim “10” na jednoj strani.
Round, red, film-coated tablets with “4” debossed on one side.
Okrugle, crvene, filmom obložene tablete s utisnutim “4” na jednoj strani.
Round, white to off-white, sublingual tablets debossed with “5” on one side.
Bijele do gotovo bijele okrugle sublingvalne tablete, s utisnutom oznakom "5" na jednoj strani.
Round, white to off-white, sublingual tablets debossed with ”10” on one side.
Bijele do gotovo bijele okrugle sublingvalne tablete, s utisnutom oznakom "10" na jednoj strani.
Round, white, coated tablets imprinted with “LILLY” and a numeric identicode “4112”.
Okrugle, bijele, obložene tablete s otisnutom oznakom “LILLY” i brojčanom identifikacijskom oznakom “4112”.
Round, white, coated tablets imprinted with “LILLY” and a numeric identicode “4115”.
Okrugle, bijele, obložene tablete s otisnutom oznakom “LILLY” i brojčanom identifikacijskom oznakom “4115”.
Round, white, coated tablets imprinted with “LILLY” and a numeric identicode “4116”.
Okrugle, bijele, obložene tablete s otisnutom oznakom “LILLY” i brojčanom identifikacijskom oznakom “4116”.
Round, white, coated tablets imprinted with “LILLY” and a numeric identicode “4117”.
Okrugle, bijele, obložene tablete s otisnutom oznakom “LILLY” i brojčanom identifikacijskom oznakom “4117”.
Roundworm
Nematodi
Roundworm and hookworm treatment (Toxocara cati and Ancylostoma tubaeforme).
Suzbijanje askarida i ankilostomida (Toxocara cati i Ancylostoma tubaeforme)
Roundworm Skin worm
Nematodi D. repens
Roundworm, hookworm and whipworm treatment (Toxocara canis, Ancylostoma caninum, Uncinaria stenocephala, Toxascaris leonina and Trichuris vulpis).
Suzbijanje askarida, ankilostomida i bičastih crva(Toxocara canis, Ancylostoma caninum, Uncinaria stenocphala, Toxascaris leonine i Trichuris vulpis)
Roundworms (Nematodes)
Oblići (nematoda)
Roundworms (Nematodes):
Oblići (nematoda)
Roundworms (Nematodes):
Oblići (nematodi)
Roundworms (Nematodes):
Oblići (nematodi):
Roundworms:
Oblići:
Route
Put primjene
Route and method of administration
Način i put primjene:
Route and method of administration
Načini davanja
Route de Belleville - Lieu-dit Maillard 01400 Châtillon-sur-Chalaronne France
Route de Belleville - Lieu-dit Maillard 01400 Châtillon-sur-Chalaronne Francuska
Route of
Način primjene
Route of
Put
Route of
Put primjene
Route of administ- ration
Put primjene
Route of administratio n
Put primjene
Route of administration
Cruzeiro i Asia1 Shamir
Route of administration
Doziranje i način primjene
Route of Administration
Léková forma
ROUTE OF ADMINISTRATION
NAČIN I PUT(EVI) PRIMJENE
ROUTE OF ADMINISTRATION
NAČIN PRIMJENE
Route of Administration
Način primjene Unutarnje
Route of administration
Način primjene:
Route of administration
Način upotrebe
Route of administration
Out prrimjene
Route of Administration
Pharmaceutical Form
Route of Administration
Pot primjene
Route of Administration
primjene
Route of administration
Put primjena
Route of Administration
Put primjene lijeka
Route of Administration
Put primjene Unutarnje
Route of administration
Put primjene:
ROUTE OF ADMINISTRATION
PUT(EVI) PRIMJENE
Route of Administration
Za primjenu u
Route of Administration Oral use
Put primjene
Route of administration Oral use
Put primjene Kroz usta
ROUTE(S) OF ADMINISTRATION
NAČIN (I) PRIMJENE
ROUTE(S) OF ADMINISTRATION
NAČIN PRIMJENE
ROUTE(S) OF ADMINISTRATION
NAČIN/I PRIMJENE
ROUTE(S) OF ADMINISTRATION
PUT(EVI) PRMJENE
ROUTE(S) OF ADMINISTRATION
PUTEVI PRIMJENE
ROUTE(S) OF ADMINISTRATION
PUTOVI PRIMJENE
Route:
Način primjene:
ROUTES OF ADMINISTRATION
PUT(EVI) PRIMJENE
ROUTES OF ADMINISTRATION
PUTEVI PRIMJENE
Routine anti-diarrhoeal agents are recommended for the treatment of diarrhoea.
Za liječenje proljeva preporučuje se primjena uobičajenih lijekova protiv proljeva.
Routine assessment of this event should include complete blood counts and physical examination.
Rutinska obrada tih događaja treba obuhvatiti kompletnu krvnu sliku i fizikalni pregled.
Routine laboratory tests may commonly reveal changes to liver functions (hyperbilirubinaemia including increased conjugated bilirubin, increased unconjugated blood bilirubin, increased blood bilirubin) as well as changes in blood count (e.g.
Rutinski laboratorijski testovi mogu otkriti promjene funkcije jetre (hiperbilirubinemija uključujući povišeni konjugirani bilirubin, povišeni nekonjugirani bilirubin u krvi, povišeni bilirubin u krvi) kao i promjene u krvnoj slici (npr.
Routine prevention of angioedema attacks in adults and adolescents 12 to 17 years old with severe and recurrent attacks of hereditary angioedema (HAE), who are intolerant to or insufficiently protected by oral prevention treatments, or patients who are inadequately managed with repeated acute treatment.
Rutinska prevencija napadaja angioedema u odraslih i adolescenata u dobi od 12 do 17 godina s teškim i ponavljajućim napadajima hereditarnog angioedema (HAE) koji ne podnose preventivno peroralno liječenje ili im ono ne pruža dovoljnu zaštitu ili u bolesnika koje se ne može primjereno zbrinuti ponavljanjem akutnog liječenja.
Routine prophylaxis was used by two subjects.
Dvoje ispitanika koristilo je rutinsku profilaksu.
Routine reversal – deep neuromuscular blockade:
Rutinska reverzija – duboka neuromuskularna blokada:
Routine reversal – moderate neuromuscular blockade:
Rutinska reverzija – umjerena neuromuskularna blokada:
ROUTINE USE
REDOVITA UPORABA
Routine Use Follow these instructions for each injection
Rutinska primjena Slijedite ove upute kod svakog injiciranja
RP > 1.15, inactivated Erysipelothrix rhusiopathiae, strain R32E11, .................
RP > 1,15 inaktivirani Erysipelothrix rhusiopathiae, strain R32E11 ..................
RP inhibition
inhibira
RP* ≥ 1
RP* ≥ 1
RP* ≥ 1
RP*≥ 1
RPLS is uncommon (it affects less than 1 in 100 people).
RPLS je manje čest (javlja se u manje od 1 na 100 osoba).
RQLQ), in all 4 studies.
Rhinoconjunctivitis Quality of Life Questionnaire) u sva 4 ispitivanja.
RR (Post-induction) CR+nCR CR+nCR+PR % (95% CI)
CR+nCR+PR % (95% CI)
RR (Post-transplant) CR+nCR CR+nCR+PR % (95%
CR+nCR+PR % (95% CI)
RR (Post-transplant) CR+nCR CR+nCR+PR % (95% CI)
CR+nCR+PR % (95% CI)
RR*: 0.69 [0.39;1.23]
RR*: 0,69 [0,39; 1,23]
RR-MS, SP-MS and single clinical event suggestive of MS
RR-MS, SP-MS i jednokratan klinički događaj koji upućuje na MS
RR-MS, SP-MS and single clinical event suggestive of MS
RR-MS, SP-MS i pojedinačni klinički poremećaj koji ukazuje na MS
RR-MS, SP-MS and single clinical event suggestive of MS
RR-MS, SP-MS i pojedinačni klinički poremećaj koji ukazuje na multiplu sklerozu
RR: 0.82 [0.33;2.00]
RR: 0,82 [0,33; 2,00]
RR: 0.87 [0.48;1.55]
RR: 0,87 [0,48; 1,55]
RRR-α-tocopherol Beta-carotene Maize oil Propylene glycol
RRR-α-tokoferol Beta-karoten Kukuruzno ulje Propilen glikol
RRRa (%) (95% CI)
RRRa(%) (95% CI)
rSBA testing performed at Public Health England (PHE) laboratories in UK
Public Health England, PHE) u Ujedinjenom Kraljevstvu
RT-PCR for PML/ RAR
RT-PCR za PML/ RAR
RTC < 15% blasts BM and PB, < 30% blasts+promyelocytes in BM and PB, < 20% basophils in PB, no extramedullary disease other than spleen and liver (only for 0102 and 0109).
RTC <15% blasta u KS i PK, <30% blasta+promijelocita u KS i PK, <20% bazofila u PK, nema ekstramedularne bolesti osim u slezeni i jetri (samo za 0102 i 0109).
RTC < 15% blasts BM and PB, < 30% blasts+promyelocytes in BM and PB, < 20% basophils in PB, no extramedullary disease other than spleen and liver.
RTC <15% blasta u KS i PK, <30% blasta+promijelocita u KS i PK, <20% bazofila u PK, nema ekstramedularne bolesti osim u slezeni i jetri.
RTC < 15% blasts BM and PB, < 30% blasts+promyelocytes in BM and PB, < 20% basophils in PB, no extramedullary disease other than spleen and liver.
RTCVraćanje na kroničnu fazu <15% blasta u KS i PK, <30% blasta+promijelocita u KS i PK, <20% bazofila u PK, nema ekstramedularne bolesti osim u slezeni i jetri.
RTC<15% blasts BM and PB, <30% blasts+promyelocytes in BM and PB, <20% basophils in PB, no extramedullary disease other than spleen and liver.
VNK <15% blasta u KS i PK, <30% blasta+promijelocita u KS i PK, <20% bazofila u PK, nema ekstramedularne bolesti osim u slezeni i jetri
Rua da Quinta do Pinheiro, 5 PT-2794-003 Carnaxide
Rua da Quinta do Pinheiro, 5
Rub gently into the area until the cream vanishes.
Kremu nježno utrljavajte dok ju koža ne upije.
rubber
Neocolipor
Rubber seal
dugme za injiciranje
Rubber Seal
Gumeni zaštitni zatvarač
Rubber seal
gumeni čep
Rubber seal
prozorčić za aktivaciju
Rubbing will not remove adhering undissolved eschar in areas where the eschar still remains.
Trljanjem se neće ukloniti prianjajući, neotopljeni eshar koji će i dalje ostati na tim područjima.
Rubella (titre ≥10 IU/mL)
≥10 IU/ml)
Rubella virus2 Wistar RA 27/3 strain (live, attenuated) not less than 3.00 log CCID *
živi, atenuirani virus rubele2, soj Wistar RA 27/3 ne manje od 3,00 log CCID
Rubella virus2 Wistar RA 27/3 strain (live, attenuated)............... not less than 3.00 log10 CCID *
živi, atenuirani virus morbila1, soj Enders' Edmonston .............. ne manje od 3,00 log10 CCID živi, atenuirani virus parotitisa1, soj Jeryl Lynn™ [Razina B] .... ne manje od 4,30 log10 CCID živi, atenuirani virus rubele2, soj Wistar RA 27/3 ....................... ne manje od 3,00 log10 CCID
Rubella virus2 Wistar RA 27/3 strain (live, attenuated)............... not less than 3.00 log10 CCID *
živi, oslabljeni virus morbila1, soj Enders' Edmonston ............... ne manje od 3,00 log10 CCID živi, oslabljeni virus parotitisa1, soj Jeryl Lynn™ [Razina B]..... ne manje od 4,30 log10 CCID živi, oslabljeni virus rubele2, soj Wistar RA 27/3........................ ne manje od 3,00 log10 CCID
Ruconest 2100 U powder for solution for injection conestat alfa
Ruconest 2100 U prašak za otopinu za injekciju konestat alfa
Ruconest contains sodium
Ruconest sadrži natrij
Ruconest is a powder that is made up into a solution for injection.
Ruconest je prašak za otopinu za injekciju.
Ruconest is given by slow injection into a vein lasting around five minutes.
Ruconest se primjenjuje polaganom injekcijom u venu koja traje otprilike pet minuta.
Ruconest is used in patients with hereditary angioedema that is linked to naturally low levels of a protein called ‘C1 esterase inhibitor’.
Ruconest se primjenjuje u bolesnika s nasljednim angioedemom koji je povezan s prirodno niskim koncentracijama proteina koji se naziva „inhibitor C1 esteraze”.
Ruconest is used to treat attacks of hereditary angioedema in adults and adolescents.
Ruconest se koristi u liječenju napadaja nasljednog angioedema u odraslih osoba i adolescenata.
Ruconest must not be used in patients with known or suspected allergy to rabbits.
Ruconest se ne smije primjenjivati u bolesnika s poznatom alergijom na kuniće ili u bolesnika za koje se sumnja da su alergični na kuniće.
Ruconest should be administered by a health care professional.
Ruconest mora primjenjivati zdravstveni radnik.
Ruconest was studied in two main studies involving a total of 70 adults and adolescents with hereditary angioedema caused by low levels of C1 esterase inhibitor protein.
Ruconest je ispitivan u dva glavna ispitivanja kojima je obuhvaćeno ukupno 70 odraslih osoba i adolescenata s nasljednim angioedemom uzrokovanim niskim koncentracijama proteina inhibitora C1 esteraze.
Rue de l'Aviation-69800 Saint Priest France
Rue de l'Aviation-69800 Saint Priest Francuska
Rue de Lyons 27460 Igoville FRANCE
Rue de Lyons 27460 Igoville FRANCUSKA
Rue de l’Aviation 69800 Saint Priest FRANCE
Rue de l’Aviation 69800 Saint Priest FRANCUSKA
Rue de l’Aviation-69800 Saint Priest FRANCE
Rue de l'Aviation-69800 SAINT PRIEST FRANCUSKA
Rue du Marquis 1 1000 Brussels Belgium
Rue du Marquis 1 1000 Brüssels Belgium
Rue Fleming 20 B-1300 Wavre Belgium
Rue Fleming 20 B-1300 Wavre Belgija
Rue Laid Burniat 1 1348 Louvain-la-Neuve BELGIUM
1348 Louvain-la-Neuve BELGIJA
Rue Laid Burniat 1 1348 Louvain-la-Neuve BELGIUM
Rue Laid Burniat 1 1348 Louvain-la-Neuve BELGIJA
Rue Laid Burniat 1 1348 Louvain-la-Neuve BELGIUM
Zoetis Belgium SA Rue Laid Burniat 1 1348 Louvain-la-Neuve BELGIJA
Rue Laid Burniat 1 1348 Louvain-la-Neuve BELGIUM
Zoetis Belgium SA Rue Laid Burniat 1 1348 Louvain-la-Neuve BELGIJUM
Rue Laid Burniat 1, 1348 Louvain-la-Neuve, BELGIUM
Rue Laid Burniat 1 1348 Louvain-la-Neuve BELGIJA
Rue Louis Leprince Ringuet
Rue Louis Leprince Ringuet 13013 Marseille
Rufinamide appears not to have a clinically relevant effect on carbamazepine, lamotrigine, phenobarbital, topiramate, phenytoin or valproate steady state concentrations.
Čini se da rufinamid nema klinički važan učinak na stanje dinamičke ravnoteže koncentracije karbamazepina, lamotrigina, fenobarbitala, topiramata, fenitoina ili valproata.
Rufinamide appears not to have clinically relevant effect on carbamazepine, lamotrigine, phenobarbital, topiramate, phenytoin or valproate steady state concentrations.
Čini se da rufinamid nema klinički važan učinak na stanje dinamičke ravnoteže koncentracije karbamazepina, lamotrigina, fenobarbitala, topiramata, fenitoina ili valproata.
Rufinamide concentrations are not subject to clinically relevant changes on co-administration with known enzyme inducing antiepileptic medicinal products.
Ne dolazi do klinički važnih promjena koncentracije rufinamida kod istovremene primjene antiepileptičkih lijekova za koje se zna da induciraju enzime.
Rufinamide has demonstrated little or no significant capacity in-vitro to act as a competitive or mechanism-based inhibitor of the following human P450 enzymes: CYP1A2, CYP2A6, CYP2C9, CYP2C19, CYP2D6, CYP2E1, CYP3A4/5 or CYP4A9/11-2.
Pokazano je da rufinamid nema nikakvu ili gotovo nikakvu značajnu sposobnost da in vitro djeluje kao kompetitivni ili na mehanizmu temeljeni inhibitor sljedećih enzima P450 u ljudi: CYP1A2, CYP2A6, CYP2C9, CYP2C19, CYP2D6, CYP2E1, CYP3A4/5 ili CYP4A9/11-2.
Rufinamide has demonstrated little or no significant capacity in-vitro to act as a competitive or mechanism-based inhibitor of the following human P450 enzymes: CYP1A2, CYP2A6, CYP2C9, CYP2C19, CYP2D6, CYP2E1, CYP3A4/5 or CYP4A9/11-2.
Pokazano je da rufinamid nema nikakvu ili gotovo nikakvu značajnu sposobnosti da in vitro djeluje kao kompetitivni ili na mehanizmu temeljeni inhibitor sljedećih enzima P450 u ljudi: CYP1A2, CYP2A6, CYP2C9, CYP2C19, CYP2D6, CYP2E1, CYP3A4/5 ili CYP4A9/11-2.
Run your finger along the adhesive pad to make sure that it sticks well.
Prstom prođite cijelom ljepljivom podlogom kako biste bili sigurni da je dobro zalijepljena na kožu.
Running a diagnostic test of your pump system is needed if you think the pump may have been damaged by water, a sporting incident, electrotherapy (cardiac defibrillator), diagnostic ultrasound or radiation (X-ray).
Potrebno je provesti dijagnostičko ispitivanje sustava pumpe ako mislite da je pumpu možda oštetila voda, sportska nezgoda, elektroterapija (srčani defibrilator), dijagnostički ultrazvuk ili ozračivanje (rendgensko snimanje).
running nose
curenje nosa
runny nose
curenje iz nosa
runny nose
curenje nosa
runny nose (rhinitis)
curenje iz nosa (rinitis)
runny nose (rhinitis)
curenje nosa (rinitis)
runny nose (rhinorrhoea)
curenje nosa (rinoreja)
runny nose and sore throat
curenje nosa i grlobolja
runny nose and sore throat
curenje nosa i suho grlo
Runny nose or nasal congestion
Curenje nosa ili začepljen nos
Runny nose or sneezing
Curenje nosa ili kihanje
runny nose,
curenje iz nosa,
runny nose, cough, hoarseness due to infection of the upper respiratory tract,
curenje iz nosa, kašalj, promuklost grla zbog infekcije gornjih dišnih putova, sinusitis, pojačani kašalj,
Runny nose, gum redness and swelling, mouth pain (including sores inside the mouth), stomach bloating, sore throat, high blood pressure, pink eye including watery eye disorder, taste loss, redness and swelling of the follicles in the skin, allergic reactions, severe scaling of the skin, increased blood clotting (including thrombosis of the veins), low levels of calcium in the blood, low levels of phosphates in the blood, upper respiratory infections, inflammation of the lung, fluid in the chest cavity, infection in the blood, dehydration, agitation, depression, numbness and tingling of the skin, dizziness, sleepiness, bleeding (from the lips, mouth, stomach or intestines), inflammation of the lining of the stomach, trouble with swallowing, skin bleeding (bruising), small pin-point haemorrage, nail disorder, acne, yeast infection, fungal infection, urinary tract infections, cystitis, blood tests that show changes in the way the liver is working, high blood fats other than triglycerides, diabetes, muscle pain.
Curenje nosa, crvenilo i oticanje desni, bol u ustima (uključujući ranice unutar usta), nadutost želuca, grlobolja, visok krvni tlak, crvenilo oka uključujući poremećaj suzenja, gubitak osjeta okusa, crvenilo i oticanje folikula na koži, alergijske reakcije, jako ljušenje kože, pojačano zgrušavanje krvi (uključujući trombozu vena), niske razine kalcija u krvi, niske razine fosfata u krvi, infekcije gornjih dišnih puteva, upala pluća, tekućina u prsnoj šupljini, infekcija krvi, dehidracija, uznemirenost, depresija, utrnulost i trnci po koži, omaglica, pospanost, krvarenje (iz usnica, usta, želuca ili crijeva), upala sluznice želuca, otežano gutanje, krvarenje u koži(modrice), mala točkasta krvarenja, poremećaj noktiju, akne, infekcija kvasnicama, gljivična infekcija, infekcije mokraćnih puteva, cistitis, krvne pretrage koje pokazuju promjene u radu jetre, visoke masnoće u krvi osim triglicerida, šećerna bolest, bol u mišićima.
runny nose, sore throat
curenje iz nosa, grlobolja
runny nose.
curenje iz nosa
runny or blocked nose
curenje iz nosa ili začepljen nos
runny or blocked nose (allergic rhinitis)
curenje iz nosa ili začepljen nos (alergijski rinitis)
runny or bloody nose, sinus problems
curenje ili krvarenja nosa, poteškoće sa sinusima
runny or stuffy nose
curenje ili začepljenost nosa
runny or stuffy nose, sneezing
curenje iz nosa ili začepljen nos, kihanje
Runny or stuffy nose, sneezing, sore throat
Curenje nosa ili začepljeni nos, kihanje, grlobolja
runny or stuffy nose.
curenje ili začepljenje nosa.
Runny/liquid stools
Meke/tekuće stolice
Runny/liquid stools.
Meke/tekuće stolice
rupture of a tendon, ligament injury
puknuće tetive, ozljeda ligamenta
rupture of the spleen
puknuće (ruptura) slezene
rupture of the spleen
ruptura slezene
Ruptured tendons.
ruptura tetiva;
RUTHERFORD- 2 (HeFH)
RUTHERFORD-2 (HeFH)
Ruxolitinib may inhibit P-glycoprotein and breast cancer resistance protein (BCRP) in the intestine.
Ruksolitinib bi mogao inhibirati P-glikoprotein i protein za rezistenciju na karcinom dojke (eng. breast cancer resistance protein, BCRP) u crijevima.
RV seasons
Razdoblja rotavirusa
Rye ergot alkaloids (ergotamine, dihydroergotamine)
Alkaloidi ražene glavice (ergotamin, dihidroergotamin)
Ryzodeg (o.d.)1
Ryzodeg (j.d.)1
Ryzodeg 100 units/mL solution for injection in cartridge
Ryzodeg 100 jedinica/ml otopina za injekciju u ulošku
Ryzodeg 100 units/mL solution for injection in cartridge 70% insulin degludec / 30% insulin aspart
Ryzodeg 100 jedinica/ml otopina za injekciju u ulošku 70% degludek inzulina / 30% aspart inzulina
Ryzodeg 100 units/mL solution for injection in cartridge EU/1/12/806/007
Ryzodeg 100 jedinica/ml otopina za injekciju u ulošku EU/1/12/806/007
Ryzodeg 100 units/mL solution for injection in pre-filled pen
Ryzodeg 100 jedinica/ml otopina za injekciju u napunjenoj brizgalici
Ryzodeg 100 units/mL solution for injection in pre-filled pen 70% insulin degludec / 30% insulin aspart
Ryzodeg 100 jedinica/ml otopina za injekciju u napunjenoj brizgalici 70% degludek inzulina / 30% aspart inzulina
Ryzodeg 100 units/mL solution for injection in pre-filled pen EU/1/12/806/001
Ryzodeg 100 jedinica/ml otopina za injekciju u napunjenoj brizgalici
Ryzodeg 100 units/mL solution for injection in pre–filled pen insulin degludec/insulin aspart
Ryzodeg 100 jedinica/ml otopina za injekciju u napunjenoj brizgalici degludek inzulin/aspart inzulin
Ryzodeg administered once-daily (o.d.) plus Oral Anti-diabetic Drugs (OADs) was compared to insulin glargine (IGlar) (o.d.) plus OADs in two trials in type 2 diabetes mellitus (Table 1).
U dva ispitivanja šećerne bolesti tipa 2 (Tablica 1), Ryzodeg primijenjen jednom dnevno (j.d.) zajedno s oralnim antidijabeticima (OAD) bio je uspoređen s glargin inzulinom (IGlar) (j.d.) zajedno s OAD.
Ryzodeg allows for flexibility in the timing of insulin administration as long as it is dosed with the main meal(s).
Ryzodeg omogućuje fleksibilnost vremena primjene inzulina sve dok se dozira uz glavni obrok (glavne obroke).
Ryzodeg b.i.d. demonstrated similar glycaemic control (HbA1c) compared with BIAsp 30 b.i.d. in patients with type 2 diabetes mellitus.
Ryzodeg d.d. pokazuje sličnu regulaciju glikemije (HbA1c) u usporedbi s BIAsp 30 d.d. u bolesnika sa šećernom bolešću tipa 2.
Ryzodeg can be administered once- or twice-daily with the main meal(s).
Ryzodeg se može primjenjivati jednom ili dva puta dnevno uz glavni obrok (glavne obroke).
Ryzodeg can be used in adolescents and children from the age of 2 years (see section 5.1).
Ryzodeg se može primjenjivati u adolescenata i djece od navršene 2 godine (vidjeti dio 5.1).
Ryzodeg can be used in elderly but you may need to check your blood sugar level more often.
Ryzodeg se može primjenjivati u starijih osoba, ali ćete možda morati češće kontrolirati razinu šećera u krvi.
Ryzodeg can be used in elderly patients but you may need to check your blood sugar level more often.
Ryzodeg se može primjenjivati u starijih osoba, ali ćete možda morati češće kontrolirati razinu šećera u krvi.
Ryzodeg can be used in renal and hepatic impaired patients.
Ryzodeg se može primjenjivati u bolesnika s oštećenjem bubrega i jetre.
Ryzodeg can either be used once or twice each day.
Ryzodeg se može primjenjivati jednom ili dva puta dnevno, svaki dan.
Ryzodeg cartridge 100
Ryzodeg uložak 100
Ryzodeg comes in a cartridge (Penfill) designed to be used with Novo Nordisk insulin delivery systems and NovoFine or NovoTwist injection needles.
Ryzodeg dolazi u obliku uloška (Penfill) namijenjenog uporabi s pomagalima za primjenu inzulina proizvođača Novo Nordisk i iglama za injekciju NovoFine ili NovoTwist.
Ryzodeg comes in a pre-filled pen (FlexTouch) designed to be used with NovoFine or NovoTwist injection needles.
Ryzodeg dolazi u obliku napunjene brizgalice (FlexTouch) namijenjene uporabi s iglama za injekciju NovoFine ili NovoTwist.
Ryzodeg contains less than 1 mmol sodium (23 mg) per dose.
Ryzodeg sadrži manje od 1 mmol (23 mg) natrija po dozi.
Ryzodeg contains two types of insulin:
Ryzodeg sadrži dvije vrste inzulina:
Ryzodeg has a rapid onset of action occurring soon after injection providing meal time coverage while the basal component has a flat and stable action profile providing continuous coverage of the basal insulin requirements.
Ryzodeg brzo počinje djelovati nakon injiciranja omogućujući pokrivanje potreba u vrijeme obroka, dok bazalni sastojak ima ravnomjeran i stabilan profil djelovanja, što omogućuje neprekidno pokrivanje potreba za bazalnim inzulinom.